Wolverine Trading, LLC Neurocrine Biosciences Inc Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $235,548 - $257,742	1,800 Added 47.37%	5,600 $770,000
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $495,520 - $546,212	3,800 New	3,800 $524,000
Q2 2022 Aug 15, 2022	SELL	$75.79 - $100.07 $530,530 - $700,490	-7,000 Reduced 46.98%	7,900 $778,000
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $854,910 - $1.12 Million	11,800 Added 380.65%	14,900 $1.38 Million
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $597,375 - $796,650	-7,500 Reduced 70.75%	3,100 $262,000
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $284,394 - $326,799	3,300 Added 45.21%	10,600 $1 Million
Q2 2021 Aug 06, 2021	BUY	$89.43 - $102.27 $178,860 - $204,540	2,000 Added 37.74%	7,300 $708,000
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $674,289 - $919,380	-7,700 Reduced 59.23%	5,300 $500,000
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $1.08 Million - $1.34 Million	-12,400 Reduced 48.82%	13,000 $1.24 Million
Q3 2020 Nov 13, 2020	SELL	$96.16 - $135.15 $230,784 - $324,360	-2,400 Reduced 8.63%	25,400 $2.48 Million
Q2 2020 Aug 13, 2020	BUY	$85.09 - $130.36 $221,234 - $338,936	2,600 Added 10.32%	27,800 $3.49 Million
Q1 2020 May 11, 2020	SELL	$75.11 - $113.76 $2.24 Million - $3.39 Million	-29,800 Reduced 54.18%	25,200 $2.31 Million
Q4 2019 Feb 12, 2020	BUY	$86.8 - $118.57 $4.77 Million - $6.52 Million	55,000 New	55,000 $5.89 Million
Q2 2019 Aug 20, 2019	SELL	$72.24 - $91.27 $5.05 Million - $6.38 Million	-69,900 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$69.31 - $91.53 $284,171 - $375,273	-4,100 Reduced 5.54%	69,900 $6.16 Million
Q4 2018 Feb 14, 2019	BUY	$68.32 - $124.36 $1.41 Million - $2.56 Million	20,600 Added 38.58%	74,000 $5.06 Million
Q3 2018 Nov 14, 2018	SELL	$98.88 - $125.85 $158,208 - $201,360	-1,600 Reduced 2.91%	53,400 $6.57 Million
Q1 2018 May 15, 2018	BUY	$75.88 - $92.43 $3 Million - $3.66 Million	39,600 Added 257.14%	55,000 $4.56 Million
Q4 2017 Feb 14, 2018	BUY	$58.53 - $77.59 $117,060 - $155,180	2,000 Added 14.93%	15,400 $1.2 Million
Q3 2017 Nov 15, 2017	BUY	$47.97 - $61.28 $642,798 - $821,152	13,400	13,400 $821,000

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.77 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.25 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$644 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$322 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$233 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account